Keith M. Skubitz

9.1k total citations · 2 hit papers
169 papers, 6.8k citations indexed

About

Keith M. Skubitz is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Keith M. Skubitz has authored 169 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 51 papers in Oncology and 42 papers in Molecular Biology. Recurrent topics in Keith M. Skubitz's work include Sarcoma Diagnosis and Treatment (40 papers), Cell Adhesion Molecules Research (40 papers) and Bone Tumor Diagnosis and Treatments (21 papers). Keith M. Skubitz is often cited by papers focused on Sarcoma Diagnosis and Treatment (40 papers), Cell Adhesion Molecules Research (40 papers) and Bone Tumor Diagnosis and Treatments (21 papers). Keith M. Skubitz collaborates with scholars based in United States, France and Australia. Keith M. Skubitz's co-authors include Amy P.N. Skubitz, Peter M. Anderson, David M. Thomas, Kenneth D. Campbell, David R. D’Adamo, Rachael C. Casey, Theodore R. Oegema, Sant P. Chawla, Jean‐Yves Blay and Robert M. Henshaw and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Keith M. Skubitz

161 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

2010 516 citations Keith M. Skubitz, Jean‐Yves Blay et al. profile →
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

2013 430 citations Jean‐Yves Blay, Keith M. Skubitz et al. profile →

Peers

Keith M. Skubitz

PRM

ONCOL

RHEUM

IMMUN

A M Gown United States

Marco Chilosi Italy

Edwin Choy United States

Francesco Bertoni Switzerland

K. Remberger Germany

Ricardo D. Coletta Brazil

Peiguo Chu United States

Mark W. Lingen United States

Gary L. Clayman United States

Katsuyuki Aozasa Japan

A M Gown United States

Keith M. Skubitz

1.8k ×0.7

PRM

1.7k ×0.9

ONCOL

2.3k ×1.2

870 ×0.5

RHEUM

1.9k ×1.7

IMMUN

Citations per year, relative to Keith M. Skubitz Keith M. Skubitz (= 1×) peers A M Gown

Countries citing papers authored by Keith M. Skubitz

Since Specialization

Citations

This map shows the geographic impact of Keith M. Skubitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith M. Skubitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith M. Skubitz more than expected).

Fields of papers citing papers by Keith M. Skubitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith M. Skubitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith M. Skubitz. The network helps show where Keith M. Skubitz may publish in the future.

Co-authorship network of co-authors of Keith M. Skubitz

This figure shows the co-authorship network connecting the top 25 collaborators of Keith M. Skubitz. A scholar is included among the top collaborators of Keith M. Skubitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith M. Skubitz. Keith M. Skubitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Skubitz, Keith M.. (2024). The role of CEACAMs in neutrophil function. European Journal of Clinical Investigation. 54(S2). e14349–e14349.

Skubitz, Keith M. & Paari Murugan. (2024). RAD51C and MYST3 Mutations in a Case of Desmoid-Type Fibromatosis With No Mutation in CTNNB1 or APC. Cureus. 16(3). e55496–e55496. 1 indexed citations

Skubitz, Keith M., Evidio Domingo‐Musibay, Bruce R. Lindgren, & Edward Y. Cheng. (2022). Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide. Cancers. 14(14). 3419–3419. 3 indexed citations

Murugan, Paari, et al.. (2021). Multiple malignant tumors in a patient with familial chordoma, a case report. BMC Medical Genomics. 14(1). 213–213.

Savani, Malvi, et al.. (2021). Pegylated liposomal doxorubicin-induced renal toxicity in retroperitoneal liposarcoma: a case report and literature review. Cancer Chemotherapy and Pharmacology. 87(2). 289–294. 12 indexed citations

Bertucci, François, Alexandre de Nonneville, Pascal Finetti, et al.. (2017). The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma. Annals of Oncology. 29(2). 459–465. 23 indexed citations

Agulnik, Mark, Ricardo Costa, Mohammed Milhem, et al.. (2016). A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas. Annals of Oncology. 28(1). 121–127. 23 indexed citations

Skubitz, Amy P.N., J. Carlos Manivel, Stephen C. Schmechel, et al.. (2013). Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Medicine. 3(1). 81–90. 21 indexed citations

Tchagang, Alain, Ahmed H. Tewfik, Amy P.N. Skubitz, & Keith M. Skubitz. (2006). A differential biclustering algorithm for comparative analysis of gene expression. European Signal Processing Conference. 1–4. 1 indexed citations

10.

Skubitz, Keith M., et al.. (2006). Differential gene expression identifies subgroups of renal cell carcinoma. Journal of Laboratory and Clinical Medicine. 147(5). 250–267. 32 indexed citations

11.

Skubitz, Keith M., et al.. (2005). Paclitaxel and pegylated‐liposomal doxorubicin are both active in angiosarcoma. Cancer. 104(2). 361–366. 153 indexed citations

12.

Alberts, David S., Franco M. Muggia, James Carmichael, et al.. (2004). Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials. Seminars in Oncology. 31(6 Suppl 13). 53–90. 114 indexed citations

13.

Skubitz, Keith M. & Amy P.N. Skubitz. (2004). Role of gene expression arrays in sarcomas. Current Oncology Reports. 6(4). 309–314. 5 indexed citations

14.

Skubitz, Keith M. & Amy P.N. Skubitz. (2004). Gene expression in aggressive fibromatosis. Journal of Laboratory and Clinical Medicine. 143(2). 89–98. 58 indexed citations

15.

Skubitz, Keith M., Kenneth D. Campbell, & Amy P.N. Skubitz. (2001). Synthetic peptides from the N‐domains of CEACAMs activate neutrophils. Journal of Peptide Research. 58(6). 515–526. 14 indexed citations

16.

Silkensen, John R., et al.. (1999). Identification of clusterin sequences mediating renal tubular cell interactions. Journal of Peptide Research. 54(5). 449–457. 13 indexed citations

17.

Monk, Peter N., et al.. (1996). A role for CD63 in signal transduction. UCL Discovery (University College London). 1 indexed citations

18.

Skubitz, Keith M., et al.. (1996). A Novel Recognition Site on Laminin for the α3β1 Integrin. Experimental Cell Research. 222(2). 281–290. 36 indexed citations

19.

Regelmann, Warren E., Keith M. Skubitz, & Jean M. Herron. (1991). Increased Monocyte Oxidase Activity in Cystic Fibrosis Heterozygotes and Homozygotes. American Journal of Respiratory Cell and Molecular Biology. 5(1). 27–33. 11 indexed citations

20.

Christiansen, Neal P., Keith M. Skubitz, Karl A. Nath, Augusto C. Ochoa, & B. J. Kennedy. (1988). Nephrotoxicity of continuous intravenous infusion of recombinant interleukin-2. The American Journal of Medicine. 84(6). 1072–1075. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact